Stoneridge sells Control Devices for $59M, posts $103M loss; CEO and CFO depart

Filed March 16, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 3, 2025 · ~2 min read

Key Changes

• high

  Sold Control Devices segment (32% of 2025 sales) for $59M in Jan 2026; recorded $21.6M impairment Q4 2025, expects $15-20M disposal loss. Credit facility reduced to $175M, extended to July 2027 with relaxed covenants (leverage ratio up to 6.75).

  Business / Notes view on EDGAR →
• high

  Net loss widened to $102.8M ($3.70/share) from $16.5M ($0.60/share) in 2024, driven by Control Devices impairment, strategic alternatives costs, and $44.3M U.S. deferred tax valuation allowance signaling reduced confidence in asset realization.

  MD&A verify on EDGAR →
• high

  CEO James Zizelman retires May 2026; President Natalia Noblet succeeds April 1. CFO Matthew Horvath resigned March 31, 2026 to pursue external opportunity. No successor named.

  Business verify on EDGAR →